We could recently show that serum GFAP might be a more suitable marker for disease progression than serum NfL, as serum levels were higher in PMS patients compared to RRMS patients and correlated with extended disability status scale (EDSS) (27), also in a multicenter cohort (28). Here, GFAP is linked to premenstrual tension.